Related Experiment Video

Updated: Jul 20, 2026

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

C-reactive protein in pediatrics

R Nudelman, B M Kagan

    Advances in Pediatrics
    |January 1, 1983
    PubMed

    Insights

    C-reactive protein (CRP) aids in diagnosing and monitoring various conditions, especially serious bacterial infections in newborns. Future research may uncover CRP abnormalities and therapeutic applications, enhancing its clinical use.

    Area of Science:

    • Clinical Chemistry
    • Immunology
    • Neonatology

    Background:

    • C-reactive protein (CRP) is a key biomarker in clinical practice.
    • Its role in diagnosing and monitoring diverse medical conditions is well-established.
    • CRP is particularly significant in neonatal care for identifying severe bacterial infections.

    Purpose of the Study:

    • To highlight the diagnostic and prognostic value of CRP.
    • To emphasize CRP's utility in neonatal infections like meningitis and septicemia.
    • To explore potential future roles of CRP in therapy and research.

    Main Methods:

    • Review of existing literature on C-reactive protein (CRP) clinical applications.
    • Analysis of CRP's significance in differential diagnosis and treatment monitoring.
    • Consideration of emerging research on CRP synthesis and function.

    Main Results:

    • CRP levels are valuable for differential diagnosis and tracking treatment response.
    • CRP is crucial for diagnosing serious neonatal bacterial infections, including meningitis and septicemia.
    • No CRP deficiency has been reported, but synthesis/function abnormalities are plausible.

    Conclusions:

    • CRP is an indispensable tool in managing various disorders, particularly in neonates.
    • Further understanding of CRP may lead to novel therapeutic strategies.
    • Increased availability of rapid CRP assays will enhance its clinical utility.

    More Related Videos

    Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry07:20

    Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry

    Published on: May 19, 2020

    Real-Time Quantification of Reactive Oxygen Species in Neutrophils Infected with Meningitic Escherichia Coli11:00

    Real-Time Quantification of Reactive Oxygen Species in Neutrophils Infected with Meningitic Escherichia Coli

    Published on: April 20, 2021

    Related Concept Videos

    Rh Blood Group01:19

    Rh Blood Group

    The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
    Relative Risk01:12

    Relative Risk

    Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

    Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
    These markers indicate stress or strain on the heart muscle:
    Natriuretic Peptides (BNP)
    Cardiac myocytes produce these hormones in response to ventricular stretching...
    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

    Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

    The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...